CRISPR, Gene Editing & DNA-Repair Antibodies

Sort by

CRISPR efficiency is only part of the result. Evaluate DNA-damage signaling, repair-pathway activation, and editing outcomes with antibodies targeting Cas9, RAD51, BRCA2, DNA-PK, γH2AX, ATM, ATR, and other key genome-stability proteins.

Collection Menu

Western blot analysis of PC3 cell lysate. Using Atrial natriuretic factor (bsm-61685R) monoclonal antibody at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at r.t. for 60 min.\r\n — Atrial natriuretic factor Recombinant Antibody

Catalog #1: bsm-61685r

Applications: WB, IP

Reactivity: Human

Conjugate: Unconjugated

Blocking buffer: 5% NFDM\/TBST\r\nPrimary ab dilution: 1:1000\r\nPrimary ab incubation condition: 2 hours at room temperature\r\nLysate: HeLa, MCF7, HepG2, A549, Jurkat\r\nProtein loading quantity: 20 \u03bcg\r\nExposure time: 180 s\r\nPredicted MW: 300 kDa\r\nObserved MW: 240 kDa — ATR Monoclonal Antibody

Catalog #1: bsm-60260M

Applications: WB

Reactivity: Human

Conjugate: Unconjugated

ATM (C-terminal region) Antibody

Catalog #1: bsm-70350M

Applications: WB, FCM, IP

Reactivity: Human

Conjugate: Unconjugated

ATM (Ser-1981), Phosphospecific Antibody

Catalog #1: bsm-70352M

Applications: WB, IP

Reactivity: Human, Mouse, Rat

Conjugate: Unconjugated